GSK (GSK) continued losses for a seventh straight session as the stock closed xx% lower, at $xx on Friday. The British ...
GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by ...
On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...
Roche announces third-quarter and nine-month results. Sanofi holds exclusive talks with CD&R to sell a 50% stake in Opella.
Antibody doses approved by Health Canada for infants; free COVID-19 and flu vaccinations available at pharmacies, doctor and ...
Progress in targeted signaling inhibition and immunotherapy has spurred a race to transform treatment across virtually all cancer disease sites. There is ample preclinical data pointing toward the ...
Cases first started to rise during the spring and have remained high through the fall, according to the Centers for Disease ...
Researchers at Intermountain Health have been awarded a $356,000 grant from Merck, a global science and technology company ...
The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for ...
Yesoul, a rising star in the exercise equipment world, is thrilled to announce the launch of its latest treadmill designed to ...
Respiratory syncytial virus, or RSV, typically presents as mild, with symptoms similar to the common cold for adults and ...